PepsiCo Isn’t The Only One Bullish On Celsius: This Analyst Explains Why It’s A Good Bet

Celsius Holdings, Inc. (NASDAQ: CELH) jumped nearly 12% higher on Monday after the announcement of it entering a long-term distribution partnership with soft-drink behemoth PepsiCo, Inc. (NASDAQ: PEP), a move that analys

Celsius Holdings, Inc. (NASDAQ:CELH) jumped nearly 12% higher on Monday after the announcement of it entering a long-term distribution partnership with soft-drink behemoth PepsiCo, Inc. (NASDAQ:PEP), a move that analyst Gianni Di Poce expected.

What Happened: The energy-drink maker stated that by making the change, the product will be available on more convenience store shelves, where about 70% of energy drinks are sold.

Di Poce called this a rumor in his weekly “Benzinga Pro Insider Report,” before the deal was announced. “There is a rumor circulating that Pepsi is looking to purchase an energy drink company and that [Celsius] CELH is a potential target,” Di Poce wrote to subscribers of his weekly report.

According to a joint statement from the two firms, PepsiCo will provide $550 million in net cash in exchange for convertible preferred shares. The announcement also stated that the shares involved in the transaction were valued at $75 each, representing an estimated 8.5% stake in Celsius stock on an “as-converted basis.”

As part of the deal, Pepsi will nominate a director to sit on the Celsius board.

“The company has grown revenue from $52 million to $314 million over the past three years,” Di Poce wrote.

“CELH has a ridiculously high valuation,” the analyst said. “P/E [price to earnings] is 646, Price-to-Sales is 16.48, and EV [enterprise value] to EBITDA is 934, but this is a sign that demand is very high for this stock.”

Also read: How Will PayPal Trade After Q2 Earnings? What The Stock Chart Says

Revenue for Celsius reached $104.3 million in 2021, nearly tripling the $35.7 million it collected in the previous year. Domestic revenues were $95.9 million, and net profits for the business fell from $8.5 million to $3.9 million in 2021.

While operating income was $7.9 million in 2020, it decreased to a $4.1 million loss a year later due to increases in selling, marketing, and general and administrative costs.

EBITDA for 2021 was reported by Celsius at $33.6 million, more than double the $16 million reported for 2020.

“From a technical perspective,” Di Poce said, “CELH just broke out from a multi-month rounding bottom pattern, which could take prices back to their former all-time highs.”
 

celsius_chart.jpg

Why It’s Happening: “CELH offers a hybrid opportunity for traders to position themselves with a consumer staples stock exhibiting strong growth,” said Di Poce. “Typically, consumer staples stocks are defensive in nature, but Celsius has growth numbers like a tech stock.”

Action Plan: “I am bullish on CELH so long as the stock remains above $77-$78,” the analyst wrote. “The upside target is $110-$112.”

Di Poce is an analyst at The Mercator, a research company dedicated to the study of economic and financial market trends.

Photo: AnnyStudio by Shutterstock

Total
0
Shares
Related Posts
Read More

Akouos, Inc., A Wholly Owned Subsidiary Of Eli Lilly Announces Phase 1/2 Clinical Trial Data For An Investigational Gene Therapy For Genetic Hearing Loss To Be Presented At The Association For Research In Otolaryngology 2024 MidWinter Meeting

Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant, the first to receive gene therapy in the United States for a genetic form of

LLY